We are pleased to announce our participation in key symposium and conferences in the field of crystallization and formulation in 2022. These meetings are the perfect opportunity to see our instruments in action and meet with a product specialist.
We are looking forward to meeting you soon!
To set up an appointment or for more information please contact us at firstname.lastname@example.org .
We participate in the following events:
|Apr 28||Launch Crystal16 - The Big Reveal||FREE Webinar|
|May 31||Webinar Crystal16 - By Dr. Carmen Guguta||FREE Webinar|
|June 7-9||FCE Pharma||Sao Paolo, Brazil|
|June 9-10||Crystal10||Lyon, France|
|June 22-24||OPRD - Booth #5||New Orleans, USA|
|July 7||Webinar Controlled Crystallization and Crystallization Inhibition.
By Dr. Thierry Bonnaud of Veranova and Dr. Carmen Guguta
|July 28||Webinar Single Crystal Perfection - Tips and Tricks
By Prof. Doris Braun and Prof. Bernhard Spingler
|August 21-25||ACS Fall - Booth #442||Chicago, USA|
|August 22-26||Achema||Frankfurt, Germany|
|August 31-2||BIWIC||Aalto, Finland|
Webinar The challenges for API crystallization processes. By Dr. Sophie Janbon (AstraZeneca)
|September 21-23||OPRD Basel||Basel, Switzerland|
|September 28-29||ILMAC 2022 - Halle 7 - Booth#A64||Lausanne, Switzerland|
|October 2-5||24th ACT Larson Workshop||Halifax, Canada|
|October 11-12||Formulation & Delivery San Diego||San Diego, USA|
|October 16-19||AAPS Boston||Boston, USA|
|November 2-3||Lab Innovations||Birmingham, UK|
|November 8-11||Solution in Chemistry||Sveti Marti na Muri, Croatia|
|November 9-11||Course on Polymorphism||Milan, Italy|
FREE WEBINAR – Clinical Phases I and II – the challenges for API crystallization processes
Would you like to know what are the challenges for API crystallization processes? And what are the scientific approaches to tackle those challenges? Would you like to know the application of these approaches showcased on drug projects?
Make sure to join a free webinar brought to you by Sophie Janbon, Director at AstraZeneca. During this session, Sophie will address Clinical Phases I and II, and the challenges for API crystallization processes.
Sophie Janbon - Director at AstraZeneca
Dr. Sophie Janbon is a French citizen, who moved to the UK in 2004 to start a Ph.D. at the School of Chemical Engineering and Analytical Sciences (SCEAS) at the University of Manchester in the group of Prof Roger Davey. Sophie's research topic was understanding crystallization pathways from thermotropic liquid crystalline states. Sophie started a Senior Crystallisation Scientist role at AstraZeneca in December 2007. Her main activity was to develop robust crystallization processes for APIs to provide suitable crystalline form and particle properties for downstream processes including efficient isolation/drying, formulation development, and drug product manufacture. These engineered physical attributes are to ensure patients are supplied with consistent and safe investigational medicines. Sophie was promoted in 2017 to Associate Principal Scientist in Crystallisation Science and then became a Team Manager in 2018 in the Early Development Phase (from pre-Lead Optimisation to Phase IIb). Her team consists of specialists including Biocatalysis, Crystallisation science, Material/Particle Science, and Process Engineering.
The slides of the presentation will be available for download after the webinar.
A recording of this webinar could be also found on this page, after the webinar.
Show details Register Now